(Q34546040)

2 August 2017

title

Lifetime risks of common cancers among retinoblastoma survivors (English)

1 reference

2 August 2017

1 reference

6

Julian Peto

1 reference

2 August 2017

2

Douglas Easton

1 reference

2 August 2017

1

Olivia Fletcher

1 reference

2 August 2017

Kristin Anderson

3

1 reference

2 August 2017

Clare Gilham

series ordinal

4

1 reference

2 August 2017

Marcelle Jay

series ordinal

5

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

Journal of the National Cancer Institute

2 August 2017

published in

1 reference

2 August 2017

volume

96

1 reference

2 August 2017

issue

5

1 reference

2 August 2017

page(s)

357-363

1 reference

A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH058

The retinoblastoma tumour suppressor in development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH058

pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH058

Retinoblastoma gene promoter directs transgene expression exclusively to the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH058

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH058

Structural alterations of the RB1 gene in human soft tissue tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH058

Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH058

Cell-cycle regulators and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH058

Truncating mutations of RB1CC1 in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH058

Non-ocular cancer in relatives of retinoblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH058

Second primary neoplasms in patients with retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH058

Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH058

Comparative value of radium and deep x rays in the treatment of retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH058

Mortality from second tumors among long-term survivors of retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH058

Relative frequency and morphology of cancers in carriers of germline TP53 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH058

Completeness of cancer registration: a new method for routine use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH058

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJH058

1 reference

2 August 2017

1 reference